Suppr超能文献

诊断和处理良性肝肿块的实用方法。

Practical approach to diagnose and manage benign liver masses.

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford, California, USA.

Department of Radiology, Stanford University, Stanford, California, USA.

出版信息

Hepatol Commun. 2024 Oct 30;8(11). doi: 10.1097/HC9.0000000000000560. eCollection 2024 Nov 1.

Abstract

Benign liver lesions are among the most commonly diagnosed abnormalities in liver imaging. They are often discovered incidentally during routine examinations or imaging conducted for unrelated reasons. These can be solid lesions, such as hemangiomas, focal nodular hyperplasia, hepatic adenomas, or cystic lesions. Recent advancements in MRI technology, particularly with hepatocyte-specific contrast agents, have enhanced the characterization of these lesions, reducing the reliance on invasive tissue sampling. Nevertheless, tissue sampling retains a crucial role in the evaluation of indeterminate lesions or those with malignant potential. While most benign liver lesions are asymptomatic, some can become symptomatic, causing discomfort, pain, or bleeding, particularly if the lesion is large. A deep understanding of the molecular underpinnings of the lesions is crucial for tailoring patient management strategies, particularly in distinguishing lesions that require surgical intervention from those that can be monitored. For instance, the molecular subclassification of hepatic adenomas has provided mechanistic insights and identified certain subtypes that are at higher risk of malignancy. Most benign liver lesions can be safely monitored; however, in patients with cirrhosis or a known primary malignancy, a high index of suspicion for cancer is required. It is crucial to carefully evaluate any liver lesion identified in these patients to ensure that indeterminate lesions are not overlooked. Effective management of benign liver lesions involves a multidisciplinary team, including hepatologists, surgeons, and radiologists, ensuring a comprehensive and individualized approach to patient care. This review outlines the clinical presentation of common benign liver lesions, providing a diagnostic and management framework. Emphasis is placed on a personalized approach to minimize patient distress and optimize outcomes by leveraging imaging advancements and multidisciplinary collaboration.

摘要

良性肝脏病变是肝脏影像学中最常见的诊断异常之一。它们通常在常规检查或因其他原因进行的影像学检查中偶然发现。这些病变可以是实性病变,如血管瘤、局灶性结节性增生、肝腺瘤或囊性病变。磁共振成像(MRI)技术的最新进展,特别是肝细胞特异性对比剂的应用,提高了这些病变的特征描述能力,减少了对有创组织采样的依赖。然而,组织采样在评估不确定或有恶性潜能的病变时仍然具有重要作用。虽然大多数良性肝脏病变是无症状的,但有些病变可能会出现症状,引起不适、疼痛或出血,特别是当病变较大时。深入了解病变的分子基础对于制定患者管理策略至关重要,特别是在区分需要手术干预的病变与可以监测的病变方面。例如,肝腺瘤的分子亚分类提供了机制见解,并确定了某些具有更高恶性风险的亚型。大多数良性肝脏病变可以安全监测;然而,在肝硬化或已知原发性恶性肿瘤患者中,需要高度怀疑癌症。仔细评估这些患者中发现的任何肝脏病变至关重要,以确保不忽视不确定的病变。良性肝脏病变的有效管理涉及多学科团队,包括肝病学家、外科医生和放射科医生,以确保对患者护理采取全面和个体化的方法。本综述概述了常见良性肝脏病变的临床表现,提供了诊断和管理框架。重点强调了个性化方法,以利用影像学进展和多学科合作,最大限度地减少患者痛苦并优化结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac1/11524743/f6be974ce174/hc9-8-e0560-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验